Exclusive

Mike Meldman, George Clooney, Rande Gerber

That’s the spirit!

George Clooney isn’t just a pretty face. It turns out the Hollywood heartthrob is also a shrewd businessman… By Darren Parkin WHEN celebrated actor George Clooney...
Black Friday in Brazil

Black Friday… welcome to the ugly side of the American sales...

By HEATHER LEAH SMITH BEFORE the sentiments of gratitude expressed over Thanksgiving dinner have had time to fade, throngs of Americans begin queuing up and...
Indra Nooyi

Passing the Pepsi test

The jewel in the crown of PepsiCo is celebrating a decade at the pinnacle of one the world’s most iconic companies – a brand...
Salmon

Scottish Salmon – What’s the catch?

It’s one of the biggest businesses in Scotland, but ask ten different experts about the state of the salmon industry and you’ll get ten...
VW badge blue bonnet

VW Sticking to its Smoking Guns

Electric dreams are no threat to the diesel engine, according to the boss of Volkswagen. Has Matthias Mueller got a cunning long-term plan, or...
Amazon

Amazon Overflowing Into New Premises

As if Amazon’s current HQ wasn’t colossal enough, the internet-based retailer is in the market for a second mega-HQ big enough for 50,000 staff....
Corporate Rebels

Workplace savants bringing magic to the daily grind

The Corporate Rebels travel the world to brighten up your working day and take a challenge to management. HAL WILLIAMS reports EVER felt overlooked and...
Paris Eiffel Tower La Defense

Macron’s Man is Sniffing Out Europe’s Business Opportunities

France’s Benjamin Griveaux is rising up the ranks of the French president’s inner circle, and he’s been handed a special mission by Emmanuel Macron...
Scales of Justice, Currencies

Fast moves mean head start in high-paced fintech arena

A LONDON-based fintech start-up profiled in BV’s feature on the recent Gibfin conference, Lendo, is making headlines for its pioneering approach towards regulated cryptocurrency. Forbes...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...